A proposed change to the new health insurance law that seeks to keep drug prices under lock and key has raised red flags.
This content was published on
2 minutes
Keystone-SDA/jdp
According to news agency Keystone-SDA, Adrian Lobsiger, the Federal Commissioner for Data Protection and Information, has written a letter criticising a confidentiality clause on the price of medicines in the proposed health insurance law.
He argues that the clauseExternal link contradicts the principle of public access. Lobsiger has already spoken out about his dissatisfaction with the provision and reiterated that it is essential that the public is able to check and monitor the price approval procedure for medicines.
Switzerland has been an advocate of price transparency. Last year, Swiss global health ambassador Nora Kronig told swissinfo.ch that “we are one of the only countries that are fully transparent about prices. There are no secret deals”.
Switzerland sets drug pricesExternal link based on a comparison to nine other countries and negotiations with individual manufacturers. But it is common knowledgeExternal link that many countries receive special discounts from companies on certain drugs. This means that the basket of prices Switzerland uses for comparison is wrong.
More
More
Government seeks to limit access to specialists to reduce healthcare costs
This content was published on
The government wants to restrict direct access for patients to specialist doctors to slow down a rise in costs for the Swiss health system.
In an effort to make innovative treatments particularly for cancer available more quickly, Switzerland also started to negotiate special rebate deals for medicines with pharmaceutical companies. Last year, public health authorities said there were deals on 20 or so treatments but this could rise with the introduction of gene therapies priced in the six to seven figures.
Although the information about the discount priceExternal link is available, some NGOs argue that it is difficult to find and calculate.
The law presented by Interior Minister Alain Berset earlier this week aims to create the legal basis for gaining access to innovative, costly medication through special deals or what are called pricing models. It suggests that in some cases the amount of the refund will not be made public in cases where the discount is so high that the company doesn’t wish to make it public.
The proposals are now available for consultation before it will be sent to parliament.
What factors should be taken into account when inheriting Swiss citizenship abroad?
Should there be a limit to the passing on of Swiss citizenship? Or is the current practice too strict and it should still be possible to register after the age of 25?
Is your place of origin, your Heimatort, important to you?
Every Swiss citizen has a Heimatort, a place of origin, but many have never visited theirs. What’s your relationship with your Heimatort? What does it mean to you?
Trump tariffs: ‘I’m a bit perplexed’, says former US ambassador to Switzerland
This content was published on
The former US ambassador to Switzerland, Edward McMullen, says he is optimistic for the Alpine country with regard to the 31% tariff on imports imposed by US President Donald Trump.
Swiss Federal Court upholds Beny Steinmetz’s bribery conviction
This content was published on
Switzerland's highest court has upheld the conviction of French-Israeli mining magnate Beny Steinmetz for bribery of foreign public officials.
This content was published on
The Trump administration has imposed a 31% tariff on imports from Switzerland. Swiss President Karin Keller-Sutter has warned against "giving in to alarmism" in an interview published on Saturday,
This content was published on
Scientists have shown that bonobos combine their calls into complex sound sequences that resemble combinations of human words.
This content was published on
US parliamentarians have threatened the UN Human Rights Council with sanctions similar to those against the International Criminal Court (ICC).
This content was published on
Thanks to abundant snowfall, lift operators benefited from increased visitor numbers, with the number of guests jumping by 12% year-on-year.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Push for drug pricing transparency strikes a nerve with industry
This content was published on
The 72nd World Health Assembly opens on Monday, but a draft resolution to end secrecy around drug pricing has already struck a nerve.
WHO adopts watered-down resolution on drug transparency
This content was published on
The World Health Organization (WHO) has adopted a resolution to improve transparency on drug prices but some people say it doesn't go far enough.
This content was published on
Curing cancer for the masses could be challenging if healthcare systems are crippled by rapidly rising cancer drug prices.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.